These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 24452425

  • 21. Evaluation of an intragastric challenge model for Shigella dysenteriae 1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment of Shigella vaccine formulations.
    Islam D, Ruamsap N, Khantapura P, Aksomboon A, Srijan A, Wongstitwilairoong B, Bodhidatta L, Gettayacamin M, Venkatesan MM, Mason CJ.
    APMIS; 2014 Jun; 122(6):463-75. PubMed ID: 24028276
    [Abstract] [Full Text] [Related]

  • 22. Shigellosis: the current status of vaccine development.
    Kweon MN.
    Curr Opin Infect Dis; 2008 Jun; 21(3):313-8. PubMed ID: 18448978
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis.
    Mitra S, Chakrabarti MK, Koley H.
    Vaccine; 2013 Jun 28; 31(31):3163-73. PubMed ID: 23684822
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
    Altboum Z, Barry EM, Losonsky G, Galen JE, Levine MM.
    Infect Immun; 2001 May 28; 69(5):3150-8. PubMed ID: 11292735
    [Abstract] [Full Text] [Related]

  • 35. Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models.
    Orr N, Robin G, Cohen D, Arnon R, Lowell GH.
    Infect Immun; 1993 Jun 28; 61(6):2390-5. PubMed ID: 8500877
    [Abstract] [Full Text] [Related]

  • 36. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.
    Tzschaschel BD, Klee SR, de Lorenzo V, Timmis KN, Guzmán CA.
    Microb Pathog; 1996 Oct 28; 21(4):277-88. PubMed ID: 8905616
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.
    Hartman AB, Van de Verg LL, Collins HH, Tang DB, Bendiuk NO, Taylor DN, Powell CJ.
    Infect Immun; 1994 Feb 28; 62(2):412-20. PubMed ID: 7507892
    [Abstract] [Full Text] [Related]

  • 39. IpaD-loaded N-trimethyl Chitosan Nanoparticles Can Efficiently Protect Guinea Pigs against Shigella flexneri.
    Akbari MR, Saadati M, Honari H, Ghorbani HM.
    Iran J Immunol; 2019 Sep 28; 16(3):212-224. PubMed ID: 31552830
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.